Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors-Reference-Cited by-同舟云学术

Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors

Published:2016-02 Issue:2 Volume:22 Page:324-329
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bregante Stefania,Dominietto Alida,Ghiso Anna,Raiola Anna Maria,Gualandi Francesca,Varaldo Riccardo,Di Grazia Carmen,Lamparelli Teresa,Luchetti Silvia,Geroldi Simona,Casarino Lucia,Pozzi Sarah,Tedone Elisabetta,Van Lint Maria Teresa,Galaverna Federica,Barosi Giovanni,Bacigalupo Andrea

Funder

Associazione Italiana Ricerca contro il Cancro

Fondazione FARITMO Genova

Imm Stuarta Genova, Fondazione CARIGE Genova

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference21 articles.

1. Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paper;Barosi;Leuk Res,2014

2. Splenectomy and hemopoietic stem cell transplantation for myelofibrosis;Li;Blood,2001

3. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation;Kröger;Blood,2009